It is a food and beverages private limited company based in Guwahati, Assam, India, established in 2013.
2013 | Guwahati, Assam, India | Struck OffMedexcel Pharmaceuticals Private Limited, a struck off private limited company, was established on 22 May 2013 in Guwahati, Assam, India. Engaging in food & beverage retail & distribution within the trade sector, it holds CIN: U24233AS2013PTC011527. Registered under ROC Roc Guwahati. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.15 M.
It upholds a active non-compliant status. Its leadership includes Kulendu Nath (Additional Director), Navadeep Kumar Borah (Director). Past directors included Banashri Bhuyan, Ankita Chaliha Goswami. Its latest AGM occurred on 30 September 2017, with the balance sheet filed on 31 March 2017. It is based at H.No 9,Beltola Namghar Path (Bahniman Path) Beltola, Near Beltola High School, Guwahati, Assam, 781028.
U24233AS2013PTC011527
011527
22 May 2013
₹0.20 M
₹0.15 M
Roc Guwahati
Unlisted
Struck Off
Explore comprehensive insights into Medexcel Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kulendu Nath | Additional Director | 06 Jun 2019 | Current |
| Navadeep Kumar Borah | Director | 22 May 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 09 Sep 2013 | Past |
| Pramod Abcsdd | Director | 06 Jun 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medexcel Pharmaceuticals Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 1257.03% increase. The company also saw a substantial improvement in profitability, with a 3333.43% increase in profit. The company's net worth Soared by an impressive increase of 48.55%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Medexcel Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Medexcel Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medexcel Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medexcel Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Kulendu Nath was appointed as a Additional Director was appointed as a Additional Director on 06 Jun 2019 & has been associated with this company since 6 years 6 months . was completed.
The activity Medexcel Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2017 as per latest MCA records. was completed.
Medexcel Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Guwahati. was recorded as a recent event.
The activity Navadeep Kumar Borah was appointed as a Director was appointed as a Director on 22 May 2013 & has been associated with this company since 12 years 7 months . was completed.
The activity Medexcel Pharmaceuticals Private Limited was registered on 22 May 2013 with Roc Guwahati & aged 12 years 7 months as per MCA records. was completed.
The CIN of Medexcel Pharmaceuticals Private Limited is U24233AS2013PTC011527.
Medexcel Pharmaceuticals Private Limited is headquartered at H.No 9,Beltola Namghar Path (Bahniman Path) Beltola, Near Beltola High School, Guwahati, Assam, 781028.
Medexcel Pharmaceuticals Private Limited was incorporated on 22 May 2013.
The current directors of Medexcel Pharmaceuticals Private Limited are
The primary industry of Medexcel Pharmaceuticals Private Limited is Trade.
Medexcel Pharmaceuticals Private Limited is unlisted.
The authorized capital of Medexcel Pharmaceuticals Private Limited is ₹0.20 M, and the paid-up capital is ₹0.15 M.
The compliance status of Medexcel Pharmaceuticals Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX